Clinical Trial Update: On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

View source ↗

Summary

A post-approval clinical registry study evaluating low-dose warfarin use in patients with an On-X aortic prosthetic heart valve, focusing on thrombotic and blee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: On-X Life Technologies, Inc. | Conditions: Thrombotic and Bleeding Events | Status: ACTIVE_NOT_RECRUITING